ArticlePloS one2023

Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry data.

Lisa J McGarry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.